Putting Amgen in Context
Check out this chart.
Phil Erlanger's Buzz & Banter post on Amgen (AMGN) raises a number of interesting points, all of which can help illustrate why understanding context is so important. If I understand correctly, the takeaway is that after a period of consolidation in August, the short intensity has turned heavy at 79% and is therefore growing increasingly bullish given the Erlanger Short Ratio and Options Rank.
Meanwhile, according to a cursory look at a point & figure chart of AMGN (see charts below courtesy Dorsey Wright), the stock remains on a sell signal, a double bottom break that occurred in August with the 79 print, and a DeMark TD-Sequential 13 (a potential exhaustion setup) has occurred on the daily chart.
The reason context is so important is that the point & figure sell signal, and the potential daily exhaustion setup, are occurring within the context of a long-term positive trend for the stock on a point & figure basis, and also within the context of a longer-term vertical price objective of 90 based on the December breakout on the 2x3 chart.
While AMGN did give a point & figure sell signal with the double bottom break recently, the primary trend is positive. This means the "sell" signal is occurring within a positive context. A more ideal setup would be a "sell" that also changes the overall context, i.e. a sell signal that also violates a trendline, or which occurs after a significant trendline has already been broken
In the case of AMGN, it could pul back to the 73-74 area (and incidentally, the downside price objective based on the vertical count is 73) and still be technically "healthy" longer-term. The problem is that the move toward that level, were it to occur, would be "corrective," not "impulsive." I do not want to short corrective moves (that is practically the definition of picking up dimes in front of a bulldozer).
With literally thousands of stocks in the universe that one can trade, it makes little sense to me to trade short against a positive context, or long against a negative context. Downside in both cases is too great compared to the potential reward.
Amgen Inc. (AMGN)
Amgen Inc. (AMGN) (2x3)
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter